Panacea Pharmaceuticals Inc.
This article was originally published in Start Up
Executive SummaryPanacea Pharmaceuticals is developing products to detect and treat CNS diseases and cancer.
You may also be interested in...
A better understanding of heme trafficking could lead to drug targets in metabolic diseases, anemias, porphyrias, hemolytic diseases such as sickle cell disease – even parasitic infections.
A series of basic research insights around the cell death process called ferroptosis could form the underpinnings of a new class of treatments aimed at drug resistant tumors.